Table 1.

Study scores allocated based on TESTEX criteria [41]

Study	1 (1 point)	2 (1 point)	3 (1 point)	4 (1 point)	5 (1 point)	6 (3 points)	7 (1 point)	8 (2 points)	9 (1 point)	10 (1 point)	11 (1 point)	12 (1 point)	Total
TESTEX criterion
Alonso-Fernandez et al. [58]	1	0	0	0	0	0	0	0	1	0	1	1	4
Alt et al. [58]	1	0	0	0	0	0	0	2	1	0	1	1	6
Anastasl and Hamzeh [56]	1	0	0	1	0	0	0	2	1	0	1	1	7
Clark et al. [51]	1	0	0	0	0	0	0	0	1	0	1	1	4
Delahunt et al. [53]	1	1	0	1	0	0	0	0	0	0	1	1	5
Freeman et al. [47]	0	0	0	1	0	1	0	1	1	0	1	1	6
lga et al. [50]	0	0	0	1	0	0	0	2	1	0	1	1	6
Ishøi et al. [35]	1	1	1	1	1	1	0	2	1	0	1	1	11
Mjolsnes et al. [33]	0	0	0	0	0	2	0	2	1	0	1	1	7
Presland et al. [54]	1	0	0	1	0	2	0	2	1	0	1	1	9
Ribeiro-Alvares et al. [51]	1	1	0	1	0	0	0	2	1	0	1	1	8
Seymore et al. [55]	1	0	0	1	0	0	0	2	1	0	1	1	7
Tansel et al. [58]	0	0	0	0	0	0	0	0	1	0	1	1	3

1 eligibility criteria specified, 2 randomization specified, 3 allocation concealment, 4 groups similar at baseline, 5 blinding of assessor; 6 outcome measures assessed in 85% of subjects, 7 intention-to-treat analysis, 8 between group statistical comparisons reported, 9 point measures and measures of variability of outcomes reported, 10 activity monitoring in control groups reported, 11 relative exercise intensity retained constant, 12 exercise volume and energy expenditure